ALC — Alcon AG Share Price
0.000.00%
Last trade - 00:00HealthcareBalancedLarge CapHigh Flyer
- $34.79bn
- $38.28bn
- $8.29bn
- 90
- 30
- 86
- 76
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 27.37 | ||
| PEG Ratio (f) | 1.31 | ||
| EPS Growth (f) | 26.4% | ||
| Dividend Yield (f) | 0.39% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.79 | ||
| Price to Tang. Book | 22.2 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.07 | ||
| EV to EBITDA | 22.48 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.65% | ||
| Return on Equity | 2.4% | ||
| Operating Margin | 7.92% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 6,792 | 7,153 | 7,508 | 6,833 | 8,291 | 8,813.97 | 9,354.4 | 4.68% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +33.98 | +16.98 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alcon AG is a Switzerland-based company specialized in the medical industry. The Company operates mainly as an eye care device company. Alcon AG reports its activities into two segments: Surgical and Vision Care. The surgical segment provides a line of ophthalmic surgical products that enable surgeons to achieve accurate results. Its surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, as well as advanced technology intraocular lenses (ATIOLs) to treat cataracts and refractive errors, such as presbyopia and astigmatism. The surgical segment also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. The Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies, as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals.
Directors
- F. Michael Ball CHM (65)
- David Endicott CEO (55)
- D. Keith Grossman VCH (61)
- Timothy Stonesifer CFO (52)
- Ian Bell CEX (50)
- Leon Duplan Fraustro CEX (53)
- Rajkumar Narayanan CEX (56)
- Sue-Jean Lin SVP
- Laurent Attias OTH (53)
- Arthur Cummings DRC (58)
- Lynn Bleil IND (57)
- Thomas Glanzmann IND (62)
- Scott Maw IND (54)
- Karen May IND (62)
- Ines Poeschel IND (52)
- Dieter Spaelti IND (60)
- Last Annual
- December 31st, 2021
- Last Interim
- March 31st, 2022
- Incorporated
- September 21st, 2018
- Public Since
- April 9th, 2019
- No. of Employees
- 24,389
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 490,100,000
- Address
- Rue Louis-d'Affry 6, FRIBOURG, 1701
- Web
- https://www.alcon.com/
- Phone
- Contact
- Karen King
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for ALC
Similar to ALC
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Agiliti
New York Stock Exchange
AmerisourceBergen
New York Stock Exchange
Artivion
New York Stock Exchange
FAQ
What is the Alcon AG share price?
As of Today at 19:00 UTC, shares in Alcon AG are trading at $70.97. This share price information is delayed by 15 minutes.
How has the Alcon AG share price performed this year?
Shares in Alcon AG last closed at $70.97 and the price had moved by +3.83% over the past 365 days. In terms of relative price strength the Alcon AG share price has outperformed the S&P500 Index by +7.86% over the past year.
What are the analyst and broker recommendations for Alcon AG?
The overall consensus recommendation for Alcon AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Alcon AG dividend yield?
The Alcon AG dividend yield is 0.31% based on the trailing twelve month period.
Does Alcon AG pay a dividend?
Last year, Alcon AG paid a total dividend of $0.22, and it currently has a trailing dividend yield of 0.31%. We do not have any data on when Alcon AG is to next pay dividends.
When does Alcon AG next pay dividends?
We do not have data on when Alcon AG is to next pay dividends. The historic dividend yield on Alcon AG shares is currently 0.31%.
How do I buy Alcon AG shares?
To buy shares in Alcon AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Alcon AG?
As of the previous close price of $70.97, shares in Alcon AG had a market capitalisation of $34.79bn.
Where are Alcon AG shares listed?
Here are the trading details for Alcon AG:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: ALC
What kind of share is Alcon AG?
Based on an overall assessment of its quality, value and momentum Alcon AG is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Alcon AG share price forecast for 2022?
The analyst consensus target price for shares in Alcon AG is $79.94. That is 12.64% above the last closing price of $70.97.
Analysts covering Alcon AG currently have a consensus Earnings Per Share (EPS) forecast of $2.44 for the next financial year.
What is the trend in the Alcon AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alcon AG. Over the past six months, its share price has underperformed the S&P500 Index by -0.27%.
As of the last closing price of $70.97, shares in Alcon AG were trading -10.34% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Alcon AG PE Ratio?
The Alcon AG PE ratio based on its reported earnings over the past 12 months is 27.37. The shares last closed at $70.97.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Alcon AG?
Alcon AG's management team is headed by:
- F. Michael Ball - CHM
- David Endicott - CEO
- D. Keith Grossman - VCH
- Timothy Stonesifer - CFO
- Ian Bell - CEX
- Leon Duplan Fraustro - CEX
- Rajkumar Narayanan - CEX
- Sue-Jean Lin - SVP
- Laurent Attias - OTH
- Arthur Cummings - DRC
- Lynn Bleil - IND
- Thomas Glanzmann - IND
- Scott Maw - IND
- Karen May - IND
- Ines Poeschel - IND
- Dieter Spaelti - IND